Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Wolf

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|November 26, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaAnupkumar George, Henry Miles Prince, Jeff Szer, et al.
Inorganic Chemistry|December 2, 2025
Positional Tuning of Photophysics and Catalysis in Methoxy-Substituted Heteroleptic Copper(I) ComplexesKurt J Haseloff, Katharina Rediger, Mohammad D Mandourah, et al.
Leukemia & Lymphoma|July 16, 2005
Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemiaFiona Chionh, Kirsten E Herbert, John F Seymour, et al.
Cancer|May 2, 2006
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphomaConstantine S Tam, Max Wolf, H Miles Prince, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapyH Miles Prince, Geoff Regester, Priscilla Gates, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
Boosting medical diagnostics by pooling independent judgmentsRalf H J M Kurvers, Stefan M Herzog, Ralph Hertwig, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.
Leukemia & Lymphoma|April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failureAshley P Ng, Andrew Wirth, John F Seymour, et al.
Cancers|April 23, 2020
Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation TherapyMichael P MacManus, Rodney J Hicks, Mathias Bressel, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|November 26, 2013
Prognostic impact of monocyte count at presentation in mantle cell lymphomaAnupkumar George, Henry Miles Prince, Jeff Szer, et al.
Inorganic Chemistry|December 2, 2025
Positional Tuning of Photophysics and Catalysis in Methoxy-Substituted Heteroleptic Copper(I) ComplexesKurt J Haseloff, Katharina Rediger, Mohammad D Mandourah, et al.
Leukemia & Lymphoma|July 16, 2005
Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemiaFiona Chionh, Kirsten E Herbert, John F Seymour, et al.
Cancer|May 2, 2006
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphomaConstantine S Tam, Max Wolf, H Miles Prince, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapyH Miles Prince, Geoff Regester, Priscilla Gates, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
Boosting medical diagnostics by pooling independent judgmentsRalf H J M Kurvers, Stefan M Herzog, Ralph Hertwig, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.
Leukemia & Lymphoma|April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failureAshley P Ng, Andrew Wirth, John F Seymour, et al.
Cancers|April 23, 2020
Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation TherapyMichael P MacManus, Rodney J Hicks, Mathias Bressel, et al.
Pageof 7